Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Clinical trial NCT00139594 · COMPLETED

Trial details

NCT number: NCT00139594
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2004-12-01
Primary completion: 2007-07-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.